CDD-1115

N/A

Report date: 2023/02/03 16:53:06
NME

Base Information

Drug NameCDD-1115
Drug Alias NameCDD-1115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone morphogenetic protein receptor type-2 inhibitors
TargetsBone morphogenetic protein receptor type-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A